Reseña histórica de la enfermedad tromboembólica venosa

Barra lateral del artículo

PDF

Contenido principal del artículo

Fernando J. Vázquez
Servicio de Clínica Médica. Hospital Italiano de Buenos Aires, Argentina

Resumen

.

##plugins.themes.bootstrap3.displayStats.downloads##

##plugins.themes.bootstrap3.displayStats.noStats##
Publicado: 10-09-2011
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v31i3.972

Detalles del artículo

Número

Vol. 31 Núm. 3 (2011): Revista del Hospital Italiano de Buenos Aires

Sección

Reseña Histórica
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Cómo citar

1.
Vázquez FJ. Reseña histórica de la enfermedad tromboembólica venosa. Rev Hosp Ital B.Aires [Internet]. 10 de septiembre de 2011 [citado 31 de julio de 2026];31(3):103-4. Disponible en: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/972

Referencias

Shapiro SS. Treating thrombosis in the 21st century. N Engl J Med. 2003;349(18):1762-4.

Mannucci PM. Venous thrombosis: the his-tory of knowledge. Pathophysiol Haemost Thromb. 2002;32(5-6):209-12.3.

Dexter L, Folch-Pi W. Venous thrombo-sis. An account of the first documented case. JAMA. 1974;228(2):195-6.

Owen CA Jr. Historical account of tests of hemostasis. Am J Clin Pathol. 1990;93(4 Suppl 1):S3-8.

Byrne JJ. Phlebitis; a study of 748 cases at the Boston City Hospital. N Engl J Med. 1955;253(14):579-86.

Egeberg O. On the natural blood coagula-tion inhibitor system. Investigations of in-hibitor factors based on antithrombin deficient blood. Thromb Diath Haemorrh. 1965;14(3-4):473-89.

Egeberg O. Inherited antithrombin defi-ciency causing thrombophilia. Thromb Diath Haemorrh. 1965;13:516-30

Egeberg O. Thrombophilia caused by inher-itable deficiency of blood antithrombin. Scand J Clin Lab Invest. 1965;17:92.

Egeberg O. An inherited hemorrhagic trait with characteristics resembling both mild hemophilia of type A and Von Willebrand's disease. Scand J Clin Lab Invest. 1965;17:Suppl 84:25-32.

Griffin JH, Evatt B, Zimmerman TS, et al. Deficiency of protein C in con-genital thrombotic disease. J Clin Invest. 1981;68(5):1370-3.

Comp PC, Esmon CT. Recurrent venous thromboembolism in patients with a par-tial deficiency of protein S. N Engl J Med. 1984;311(24):1525-8.

Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously un-recognized mechanism characterized by poor nticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90(3):1004-8.

Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64-7.

Kalafatis M, Haley PE, Lu D, et al. Pro-teolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance as-say. Blood. 1996;87(11):4695-707